GlaxoSmithKline Pharma

3219.00

+19.80 (0.62%) tick

NSE

Buy Sell

NSE BSE

Last updated on 20 Jun 2025 02:51 PM

Open Demat account

Returns

-2.38%

Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

54108.29

Earning Per Share

54.25

Dividend Yield

1.88%

P/E Ratio

53.04

P/B Ratio

27.76

Debt to Equity

0.01

Performance

min-value

max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value

max-value

5.34% down side

up side5.34%

About the company

GlaxoSmithKline Pharmaceuticals Limited was erstwhile incorporated as 'Glindia Limited' in November, 1924. The Company' s name was changed to Glaxo (India) Limited' from Glindia Limited in year 1987 and further to 'GlaxoSmithKline Pharmaceuticals Limited' from Glaxo (India) Limited effective from October 22, 2001. GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together. The Company is headquartered in Mumbai and it has six branch offices, one manufacturing facility at Nashik in Maharashtra, 20 contract manufacturing organisations (CMOs) with regional and sales hubs across India. The Company is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals.

Similar Companies

Abbott India

31580 +550.00 (0.02%) tick

1Yr Returns

+15.33%

Pfizer

5690.5 +26.50 (0.00%) tick

1Yr Returns

+18.33%

Astrazeneca Pharma

9006.5 -404.00 (-0.04%) tick

1Yr Returns

+47.44%

Sanofi India

6056 +25.50 (0.00%) tick

1Yr Returns

-12.87%

Sanofi Cons Healthc Ind L

5125.5 +114.00 (0.02%) tick

1Yr Returns

+2.2%